| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |